AZO vs DMAC · P/E 21, rev $18.94B vs $157.4M cap
AutoZone Inc (AZO) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
DMAC does not have a complete income-statement cache yet.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the AZO and DMAC stock pages for the full models.
Not investment advice.